Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

about

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

Item

http://www.wikidata.org/entity/Q50611105

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

@en

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

@nl

type

Item

label

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

@en

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

@nl

prefLabel

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

@en

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

@nl

P1476

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

@en

P2093

Adrian Hepner

http://www.w3.org/2001/XMLSchema#string

Bassam Mattar

http://www.w3.org/2001/XMLSchema#string

Brian Chanas

http://www.w3.org/2001/XMLSchema#string

Eric M Cheung

http://www.w3.org/2001/XMLSchema#string

Mark Smith

http://www.w3.org/2001/XMLSchema#string

Peter J Mutch

http://www.w3.org/2001/XMLSchema#string

Stephen P Anthony

http://www.w3.org/2001/XMLSchema#string

William J Edenfield

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.

Bendamustine pharmacokinetic profile and exposure-response relationships in patients with indolent non-Hodgkin's lymphoma.

Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.

A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients.

Improving wait time for chemotherapy in an outpatient clinic at a comprehensive cancer center

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration.

A randomized trial of dietary sodium restriction in CKD

Significance of hypo- and hypernatremia in chronic kidney disease.

P304

1400-1408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.942

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28561902

http://www.w3.org/2001/XMLSchema#string